| Finding | Percentage | Cases |
|---|---|---|
| Gender | ||
| Male | 54.3% | 19/35 |
| Female | 45.7% | 16/35 |
| Indifferent | 0% | 0/35 |
| Unknown | 0% | 0/35 |
| General | ||
| 11.4% | 4/35 | |
| 14.3% | 5/35 | |
| 5.7% | 2/35 | |
| 25.7% | 9/35 | |
| 34.3% | 12/35 | |
| 31.4% | 11/35 | |
| 60% | 21/35 | |
| 71.4% | 25/35 | |
| 48.6% | 17/35 | |
| 46.7% | 7/15 | |
| Neurology | ||
| 57.1% | 20/35 | |
| 37.1% | 13/35 | |
| 40% | 14/35 | |
| Facial abnormalities | ||
| 54.3% | 19/35 | |
| 100% | 35/35 | |
| 45.7% | 16/35 | |
| 71.4% | 25/35 | |
| Visual and hearing impairments | ||
| 17.1% | 6/35 | |
| 54.3% | 19/35 | |
| Heart | ||
| 40% | 14/35 | |
| Pulmonary | ||
| 5.7% | 2/35 | |
| Gastrointestinal | ||
| 25.7% | 9/35 | |
| Urogenital | ||
| 31.4% | 11/35 | |
| Skeleton | ||
| 65.7% | 23/35 | |
| Skin / Hair / Nails | ||
| 40% | 14/35 | |
| Endocrine / Immunological / Metabolic | ||
| 2.9% | 1/35 | |
| Metabolic | 0% | 0/35 |
| 2.9% | 1/35 | |
| Neoplasia | ||
| Neoplasia | 0% | 0/35 |
| Inheritance | ||
| 81.3% | 26/32 | |
